Developing countries face a seemingly insurmountable hurdle in providing healthcare to their rapidly growing — or, in some cases, rapidly aging — populations, especially as health systems become increasingly over-burdened and infections and other diseases spread. Because access to medicine in these regions is a multifaceted challenge, it is best tackled by several parties.
Lasting, collaborative relationships among pharmaceutical companies, governments, nonprofit organizations and community leaders are needed to help disadvantaged populations overcome their healthcare challenges. Together, these parties should take a binary approach, addressing both “hardware” factors (which remain constant, such as physical distance to treatment centers and elongated supply chains) and “software” factors (the intangibles that vary greatly in each region, such as the role of family and cultural beliefs).
These principles are especially true in places like China’s rural Xinjiang Uighur Autonomous Region, where life expectancy is stunted at 67 years (compared with 73.5 for China as a whole), and lack of access to healthcare undermines well-being. Xinjiang covers nearly 1.7 million square kilometers, but it is home to only 21 million people, many of whom are members of nomadic tribes. From an economic standpoint, Xinjiang’s resilience is crucial to China’s economic growth strategy — it is seen as the country’s gateway to the West.
However, the reality is that maintaining the livelihood and well-being of this area’s population and those in other rural parts of China is a serious challenge. Throughout rural China, the spread of infectious diseases — particularly hepatitis B, which affects millions — reflects a lack of hygiene education. The Chinese Ministry of Health cited a 9.5 percent increase in deaths caused by infectious diseases from 2011 to last year. Moreover, there is a serious shortage of healthcare workers — just 1.3 per 1,000 rural inhabitants in China.
Free medicines are only part of the solution. We need to go beyond donations and reduced-pricing schemes to build sustainable healthcare systems with strong distribution channels and education programs for the public and for healthcare workers. Without these components, the model collapses.
Through public-private partnerships, we can leverage unique strengths and be better equipped to expand access to healthcare. This can create a symbiotic relationship, offering benefits to government, business and the local community.
For example, Novartis’ Jian Kang Kuai Che (“Health Express”) program in Xinjiang is a partnership between Novartis and the local government that aims to expand access to medicine, build capacity and educate the public. Health Express achieves this by training local physicians in prevention and treatment of infectious diseases and educating primary and middle-school students on health and hygiene via a traveling caravan that moves from school to school.
During a recent trip to Xinjiang, I met several physicians from rural hospitals who had received training through Health Express. They told me that in the past, hepatitis patients had to travel for hours to be diagnosed and treated at a city hospital, while many others who were unable to make the journey suffered without treatment. Now, with physicians trained in infectious diseases, hepatitis treatment is possible in rural areas of Xinjiang, and patient outcomes have improved significantly.
I also met with school children at Urumqi Dengcaogou Boarding School, which is situated in a rural area outside of the provincial capital. The students were proud to be able to bring their new healthcare knowledge back to their families. They told me how they had told their parents to quit smoking after learning about the consequences of the habit on health.
These children join more than 500,000 others in Xinjiang who have participated in the educational component of Health Express. By targeting schools as hubs for healthcare education and shaping students into health ambassadors for their families and friends, we can reach an even greater number of people in Xinjiang’s nomadic communities.
Xinjiang means “new frontier,” and right now, we are at the edge of a new frontier in delivering sustainable healthcare solutions to communities where limited resources and infrastructure constrain access to healthcare. These multidimensional, scalable interventions help to bridge the gaps in developing regions.
However, neither corporations nor governments can do it alone. They need to work together to achieve the best possible outcome. We must also abandon the idea of a one-size-fits-all model for expanding access to healthcare and adjust our approaches to ensure the best fit with local health priorities and customs. With education and prevention, capacity-building and new kinds of partnerships, we can continue to improve access to healthcare in Xinjiang and beyond, boosting well-being throughout the developing world.
Joseph Jimenez is chief executive officer of Novartis.
Copyright: Project Syndicate
Congressman Mike Gallagher (R-WI) and Congressman Raja Krishnamoorthi (D-IL) led a bipartisan delegation to Taiwan in late February. During their various meetings with Taiwan’s leaders, this delegation never missed an opportunity to emphasize the strength of their cross-party consensus on issues relating to Taiwan and China. Gallagher and Krishnamoorthi are leaders of the House Select Committee on the Chinese Communist Party. Their instruction upon taking the reins of the committee was to preserve China issues as a last bastion of bipartisanship in an otherwise deeply divided Washington. They have largely upheld their pledge. But in doing so, they have performed the
It is well known that Chinese President Xi Jinping’s (習近平) ambition is to rejuvenate the Chinese nation by unification of Taiwan, either peacefully or by force. The peaceful option has virtually gone out of the window with the last presidential elections in Taiwan. Taiwanese, especially the youth, are resolved not to be part of China. With time, this resolve has grown politically stronger. It leaves China with reunification by force as the default option. Everyone tells me how and when mighty China would invade and overpower tiny Taiwan. However, I have rarely been told that Taiwan could be defended to
It should have been Maestro’s night. It is hard to envision a film more Oscar-friendly than Bradley Cooper’s exploration of the life and loves of famed conductor and composer Leonard Bernstein. It was a prestige biopic, a longtime route to acting trophies and more (see Darkest Hour, Lincoln, and Milk). The film was a music biopic, a subgenre with an even richer history of award-winning films such as Ray, Walk the Line and Bohemian Rhapsody. What is more, it was the passion project of cowriter, producer, director and actor Bradley Cooper. That is the kind of multitasking -for-his-art overachievement that Oscar
Chinese villages are being built in the disputed zone between Bhutan and China. Last month, Chinese settlers, holding photographs of Chinese President Xi Jinping (習近平), moved into their new homes on land that was not Xi’s to give. These residents are part of the Chinese government’s resettlement program, relocating Tibetan families into the territory China claims. China shares land borders with 15 countries and sea borders with eight, and is involved in many disputes. Land disputes include the ones with Bhutan (Doklam plateau), India (Arunachal Pradesh, Aksai Chin) and Nepal (near Dolakha and Solukhumbu districts). Maritime disputes in the South China